Nateglinide

Nateglinide is an N-acyl-D-phenylalanine resulting from the formal condensation of the amino group of D-phenylalanine with the carboxy group of trans-4-isopropylcyclohexanecarboxylic acid. An orally-administered, rapidly-absorbed, short-acting insulinotropic agent, it is used to treat type 2 diabetes mellitus. Among its listed roles, it functions as a EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor and a hypoglycemic agent. It is grouped under the following drug class(es): Hypoglycemics. Its therapeutic use is listed as antidiabetic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Starlix, Starsis and senaglinide. Its PubChem CID is 5311309.

CAS No 105816-04-4
Molecular Formula C19H27NO3
Molecular Weight 317.4 g/mol
Synonyms (2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid

Frequently Asked Questions